Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
autoimmune disease
Biotech
Dianthus offers up to $1B for China biotech’s autoimmune asset
Dianthus is offering Leads Biolabs up to $1 billion biobucks for licensing rights to an investigational autoimmune disease treatment.
Gabrielle Masson
Oct 16, 2025 10:57am
Diabetes drug soothes brain inflammation in female mice with MS
Oct 15, 2025 6:16pm
Cabaletta's CAR-T wipes out B cells with no preconditioning
Oct 10, 2025 11:11am
BMS inks $1.5B deal to pull Orbital into its sphere of influence
Oct 10, 2025 8:45am
3 scientists win Nobel Prize for discovery of regulatory T cells
Oct 6, 2025 7:03am
Barinthus enters reverse merger with metabolic disease biotech
Sep 30, 2025 10:39am